Skip to main content
SpringerLink
Log in

Influence of Phosphodiesterase Inhibitors on Aerobic Capacity in Chronic Heart Failure

  • Conference paper
Computerized Cardiopulmonary Exercise Testing

  • 87 Accesses

Abstract

The diagnostic potential of exercise testing has been considerably enhanced by the concurrent measurement of respiratory gas exchange. The availability of rapidly responding gas analyzers together with linear air flow transducers have greatly facilitated the on-line monitoring of oxygen uptake (\(\dot V\)O2), carbon dioxide production (\(\dot V\)CO2), and minute ventilation (\(\dot V\)E) in the clinical exercise laboratory.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bairn DS, McDowell AV, Cheniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W (1983) Evaluation od a new bypiridine inotropic agent-milrinone-in patients with severe chronic congestive heart failure. N Engl J Med 309: 748–756

    Article  Google Scholar 

  2. Benge W, Litchfield RL, Marcus ML (1980) Exercise capacity in patients with severe left ventricular dysfunction. Circulation 61: 955–959

    PubMed  CAS  Google Scholar 

  3. Benotti JR, Grossman W, Braunwald E, Davolos DD, Alousi AA (1978) Hemodynamic assessment of amrinone: a new positive inotropic agent N Engl J med 299: 1373–1377

    CAS  Google Scholar 

  4. Choong CYP, Roubin GS, Shen WFm Harris PJ, Kelly DT (1985) Effects of nifedipine on systemic and regional oxygen transport and metabolism at rest and during exercise Circulation 71: 787–796

    CAS  Google Scholar 

  5. Choraria SK, Taylor D, Picher J (1987) Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure. Circulation 76: 1307–1311

    Article  PubMed  CAS  Google Scholar 

  6. Colluci WS, Wright RF, Braunwald E (1986) New positive inotropic agents in the treatment of congestive heart failure N Engl J Med 414: 290–299, 349–358

    Google Scholar 

  7. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant R, Wright R (1989) Oral milrinone and digoxin in patients with chronic heart failure: N Engl J Med 320: 677–673

    Google Scholar 

  8. Drexler H, Faude F, Hoing S, Just H (1987) Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. Circulation 76: 1344–52

    Article  PubMed  CAS  Google Scholar 

  9. Drexler H, Banhardt U, Meinertz T, Wollschläger H, Lehmann M, Just H (1989) Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. Circulation 79: 491–502

    Article  PubMed  CAS  Google Scholar 

  10. Franciosa JA, Ziesche S, Wilen M (1979) Functional capacity of patients with chronic heart left ventricular failure. Am J Med 67: 460–466

    Article  PubMed  CAS  Google Scholar 

  11. Franciosa JA, Park M, Levine B (1981) Lack of relation between exercise capacity and indices of resting left ventricular performance in heart failure. Am J Cardiol 47: 33–39

    Article  PubMed  CAS  Google Scholar 

  12. Froelicher VF (1987) Exercise and the heart: Clinical concepts 2nd ed Chicago Year Book Medical Publishers, Inc.

    Google Scholar 

  13. Higginbotham MB, Morris RG, Conn EH, Coleman RR, Cobb FR (1985) Determinants of variable exercise performance among patients with severe left ventricular dysfunction Am J Cardiol 51: 52–60

    Google Scholar 

  14. Kramer BL, Massie BM, Topic N (1983) Controlled trial of captopril in chronic congestive heart failure. Am J Cardiol 67: 807–816

    CAS  Google Scholar 

  15. Leier CV, Binkley PF, Starling RC, Randolph PH (1989) Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy. Am Heart J 117: 1089–1092

    Article  Google Scholar 

  16. Likoff MJ, Weber KT, Janicki JS, Wilson et al. (1985) Milrinone in the treatment of chronic cardiac failure: A controlled trial. Am Heat J 110: 1035–1042

    Article  CAS  Google Scholar 

  17. Likoff MJ, Chandler SL, Kay HR (1987) Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 59: 634–638

    Article  PubMed  CAS  Google Scholar 

  18. Maskin CS, Forman R, Sonnenblick H, Frishman WH, LeJemtel TH (1983) Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe congestive heart failure. Am J Cardiol 51: 177–182

    Article  PubMed  CAS  Google Scholar 

  19. Matsumura N, Nishijima H, Kojima S, Hashimoto F, Minami M, Yadsuda H (1983) Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure. Circulation 68: 360–367

    Article  PubMed  CAS  Google Scholar 

  20. Nemanich JW, Shurman AJ, Rossen JD, Kremser C, Davis F, Faifer SI (1987) Effects of longterm therapy with oral piroximone on resting hemodynamics, peak aerobic capacity and the anaerobic threshold in patients with chronic heart failure. J Cardiovasc Pharmacol 10: 580–588

    Article  PubMed  CAS  Google Scholar 

  21. Ribeiro JP, White HD, Arnold JMO, Artley LH, Colucci WS (1986) Exercise response before and after longterm treatment with oral milrinone in patients with severe heart failure. Am J Med 81: 759–764

    Article  PubMed  CAS  Google Scholar 

  22. Rubin SA, Chatterjee K, Parmley WW (1980) Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators. Circulation 61: 543–548

    PubMed  CAS  Google Scholar 

  23. Scriven AJI, Lipkin DP, Sutton GC, Poole-Wilson PA (1988) Double-blind randomized cross over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe chronic heart failure. J Cardiovasc Pharmacol 11: 45–50

    Article  PubMed  CAS  Google Scholar 

  24. Sullivan MJ, Knight JD, Higginbothan MB, Cobb FR (1989) Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Circulation 80: 769–781

    Article  PubMed  CAS  Google Scholar 

  25. Szlachic J, Massie BM, Kramer BL, Topic N, Tubau J (1985) Correlates and prognostic implication of exercise capacity in congestive heart failure Am J Cardiol 55: 1037–1042

    Google Scholar 

  26. Treese N, Erbel R, Rhein S, Henrichs KJ, Meyer J (1989) Additive effects of enoximone and nitroprusside in unstable chronic heart failure. Eur Heart J 10: 484–492

    PubMed  CAS  Google Scholar 

  27. Treese N, Erbel R, Rhein S, Coutinho M, Meyer J (1990) Aerobic capacity in chronic heart failure: a randomized long-term comparison of captopril and enoximone J Am Col Cardiol 15 (2): 150A

    Google Scholar 

  28. Uretsky BF, Generalovich T, Reddy PS, Spangenberg RB, Follansbee WP (1983) The acute hemodynamic effects of a new agent, MDL 17.043 in the treatment of congestive heart failure. Circulation 62: 823–828

    Article  Google Scholar 

  29. Wasser am K, Hansen JE, Sue DY, et al. (1987) Principles of exercise testing and interpretation. Philadelphia, Lea & Febinger

    Google Scholar 

  30. Weber KT, Andrews V, Janicki JS, Wison JR, Fishman AP (1981) Amrinone and exercise performance in patients with chronic heart failure. Am J Cardiol 48: 164–169

    Article  PubMed  CAS  Google Scholar 

  31. Weber KT, Andrews V, Janicki JS, Likoff M, Reicheck N (1982) Pirbuterol an oral beta adrenergic receptor agonist, in the treatment of chronic heart failure. Circulation 66: 1262

    Article  PubMed  CAS  Google Scholar 

  32. Weber KT, Janicki JS (1985) Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 55 (SupplA): 22A - 31A

    Article  PubMed  CAS  Google Scholar 

  33. Weber KT, Janicki JS, Jain MC (1986) Enoximone (MDL 17.043) for stable chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Am J Cardiol 58: 589–595

    Article  PubMed  CAS  Google Scholar 

  34. Weber KZ, Janicki JS (1986) Cardiopulmonary exercise testing. Philadelphia, WB Saunders Co.

    Google Scholar 

  35. Weber KT, Janicki JS, Jain MC (1987) Piroximone (MDL 19.205) in the treatment of unstable and stable chronic heart failure. Am Heart J 114: 805–813

    Article  PubMed  CAS  Google Scholar 

  36. Wilson JR, Martin JL, Ferraro N, Weber KT (1983) Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure. Circulation 68: 425–432

    Article  PubMed  CAS  Google Scholar 

  37. Wilson JR, Martin JL, Schwartz D, Ferraro N (1984) Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 69: 1079–1087

    Article  PubMed  CAS  Google Scholar 

  38. Zelis R, Longhurst J, Capone RJ, Mason DT (1974) Comparison of regional blood flow and oxygen utilization during dynamic exercise in normal subjects and patients with congestive heart failure. Circulation 50: 137–143

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II. Medizinische Klinik, Langenbeckstr. 1, D-6500, Mainz, Germany

    Prof. Dr. Norbert Treese

  2. II. Medizinische Klinik, Joh.-Gutenberg-Universität, Mainz, Germany

    Prof. Dr. Norbert Treese, M. Coutinho, A. Werneyer, S. Rhein, R. Erbel & J. Meyer

Authors
  1. Prof. Dr. Norbert Treese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Coutinho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Werneyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Rhein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Erbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik III für Innere Medizin, Universität Köln, Joseph-Stelzmann-Str. 9, 5000, Köln 41, Deutschland

    U. J. Winter  & H. W. Höpp  & 

  2. Harbor UCLA, 1000 W. Carson Street, 90509, Torrance, CA, USA

    K. Wasserman

  3. II. Medizinische Klinik und Poliklinik, Universität Mainz, Langenbeckstraße 1, 6500, Mainz, Deutschland

    N. Treese

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Treese, N., Coutinho, M., Werneyer, A., Rhein, S., Erbel, R., Meyer, J. (1991). Influence of Phosphodiesterase Inhibitors on Aerobic Capacity in Chronic Heart Failure. In: Winter, U.J., Wasserman, K., Höpp, H.W., Treese, N. (eds) Computerized Cardiopulmonary Exercise Testing. Steinkopff. https://doi.org/10.1007/978-3-642-85404-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85404-0_10

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85406-4

  • Online ISBN: 978-3-642-85404-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation